HERON THERAPEUTICS, INC. /DE/ Adjustments to Additional Paid in Capital, Warrant Issued
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Adjustments to Additional Paid in Capital, Warrant Issued of $371.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-02-26
- HERON THERAPEUTICS, INC. /DE/ adjustments to additional paid in capital, warrant issued for the quarter ending 2023-09-30 was $371.00K.
- HERON THERAPEUTICS, INC. /DE/ adjustments to additional paid in capital, warrant issued for fiscal 2023 was $371.00K.
- HERON THERAPEUTICS, INC. /DE/ adjustments to additional paid in capital, warrant issued for fiscal 2017 was $226.00K.
- HERON THERAPEUTICS, INC. /DE/ adjustments to additional paid in capital, warrant issued for fiscal 2012 was $180.00K, a 500.00% increase from fiscal 2011.
- HERON THERAPEUTICS, INC. /DE/ adjustments to additional paid in capital, warrant issued for fiscal 2011 was $30.00K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2023-12-31 | $371.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $371.00K 10-Q · filed 2024-11-12 | |
| 2017-12-31 | $226.00K 10-K · filed 2020-03-02 | |
| 2012-12-31 | $180.00K 10-K · filed 2015-03-13 | |
| 2011-12-31 | $30.00K 10-K · filed 2014-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |